IP Library Granted Patent US 9,381,343
Granted Patent B2
US 9,381,343 · App. 14/536,951 · Granted Jul 5, 2016

Systems and methods for treating shoulder pain related to subacromial impingement syndrome

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,381,343
App. No.
14/536,951
Granted
Jul 5, 2016
Kind
B2
Abstract

Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.

Claims (37)

1. A method comprising the steps of:

percutaneously inserting a lead into a patient;

placing an electrode in subepidermal tissue of the patient, the electrode operatively coupled with the lead; and

delivering electrical stimulation through the electrode producing a muscle contraction in a target area and altering maladaptive neuroplasticity in a central nervous system of the patient producing a therapeutic effect.

2. The method of claim 1 wherein during the delivering step, a level of pain perceived by the patient, whereby the pain was caused by or occurring secondarily to subacromial impingement syndrome, is reduced.

3. The method of claim 1 , wherein the patient is a human.

4. The method of claim 1 , wherein the lead is attached with the electrode.

5. The method of claim 1 , wherein the electrode is formed as part of the lead.

6. The method of claim 1 , wherein the electrode is carried on the lead.

7. The method of claim 1 , wherein the electrode extends from a conductor attached with the lead.

8. The method of claim 1 , wherein the lead includes a portion having an insulated body and the electrode is formed from a portion of the lead free of the insulated body.

9. A method comprising the steps of:

percutaneously inserting a lead into a patient;

placing an electrode in subepidermal tissue of the patient, the electrode operatively coupled with the lead; and

delivering electrical stimulation through the electrode to generate a muscle contraction in a target area and reduce central hypersensitivity in the patient producing a therapeutic effect.

10. The method of claim 9 , wherein parameters of the electrical stimulation comprise 12 Hz, 20 mA and a pulse duration of 60 μs.

11. The method of claim 1 , wherein the therapeutic effect is a reduction in pain.

12. The method of claim 9 , wherein the electrode is spaced an electrically effective distance from a neurological motor point.

13. The method of claim 9 , wherein the reduction central hypersensitivity in the patient reduces chronic pain in the patient.

14. The method of claim 13 , wherein the pain is caused by or secondarily to subacromial impingement syndrome.

15. The method of claim 9 , wherein the electrode is spaced an electrically effective distance from a neurological motor point.

16. The method of claim 9 , wherein the therapeutic effect is a reduction in pain.

17. A method comprising the steps of:

percutaneously inserting a lead into a patient;

placing an electrode in subepidermal tissue of the patient, the electrode operatively coupled with the lead; and

delivering electrical stimulation through the electrode to generate a muscle contraction in a target area and sustain functional reorganization of maladaptive neuroplastic changes of a nervous system of the patient associated with chronic pain.

18. The method of claim 17 , wherein the electrode is spaced an electrically effective distance from a neurological motor point.

19. The method of claim 17 , wherein parameters of the electrical stimulation comprise 12 Hz, 20 mA and a pulse duration of 60 μs.

20. A method comprising the steps of:

percutaneously inserting a lead into a tissue of a human; and

delivering stimulation through at least one electrode operatively coupled with the lead to a neurological motor point of the human generating a muscle contraction in a target area changing central nervous system maladaptive neuroplasticity of the human producing a therapeutic effect.

21. The method of claim 20 , wherein the electrode is spaced an electrically effective distance from the neurological motor point.

22. The method of claim 20 , wherein parameters of the stimulation comprise 12 Hz, 20 mA and a pulse duration of 60 μs.

23. The method of claim 20 , wherein the at least one electrode consists of a single electrode.

24. The method of claim 20 , wherein the delivering step relieves chronic pain.

25. The method of claim 20 , wherein parameters of the electrical stimulation comprise 12 Hz, 20 mA and a pulse duration of 60 μs.

26. The method of claim 20 , wherein the therapeutic effect is a reduction in pain.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066526/0025 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0721 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0676 →
CHANGE OF NAME Recorded Dec 6, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044716/0812 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044414/0575 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044715/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2016
From: BENNETT, MARIA E.; BOGGS, JOSEPH W., II; CHAE, JOHN
To: SPR THERAPEUTICS, LLC
Reel/Frame 038800/0732 →